{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:34:59Z","timestamp":1791279299779,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bcp.2014.03.015","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T16:01:06Z","timestamp":1397318466000},"page":"536-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats"],"prefix":"10.1016","volume":"89","author":[{"given":"Michael F.","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"McGaraughty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine L.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wende","family":"Niforatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Milicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailen","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.03.015_bib0005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuron.2010.08.021","article-title":"Ion channel voltage sensors: structure, function, and pathophysiology","volume":"67","author":"Catterall","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2014.03.015_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Ann Rev Cell Dev Biol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","article-title":"Role of voltage-gated calcium channels in ascending pain pathways","volume":"60","author":"Zamponi","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bcp.2014.03.015_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/187152706779025490","article-title":"The role of T-type calcium channels in peripheral and central pain processing","volume":"5","author":"Todorovic","year":"2006","journal-title":"CNS Neurol Dis Drug Targ"},{"key":"10.1016\/j.bcp.2014.03.015_bib0025","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1523\/JNEUROSCI.4866-06.2007","article-title":"Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons","volume":"27","author":"Jagodic","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0030","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1152\/jn.01031.2007","article-title":"Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve","volume":"99","author":"Jagodic","year":"2008","journal-title":"J. Neurophys"},{"key":"10.1016\/j.bcp.2014.03.015_bib0035","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1523\/JNEUROSCI.1598-04.2004","article-title":"Role of T-type calcium current in identified D-hair mechanoreceptor neurons studied in vitro","volume":"24","author":"Dubreuil","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0040","first-page":"638","article-title":"Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size","volume":"445","author":"Scroogs","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nn1076","article-title":"A T-type calcium channel required for normal function of a mammalian mechanoceptor","volume":"6","author":"Shin","year":"2003","journal-title":"Nat Neursci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0050","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999","article-title":"Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels","volume":"19","author":"Talley","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.emboj.7600515","article-title":"Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception","volume":"24","author":"Bourinet","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2014.03.015_bib0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1601-183X.2006.00268.x","article-title":"Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels","volume":"6","author":"Choi","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.bcp.2014.03.015_bib0065","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1476-5381.2011.01256.x","article-title":"T-type voltage-gated calcium channels as targets for the development of novel pain therapies","volume":"163","author":"Todorovic","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0070","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, A potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.03.015_bib0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/jpet.110.166363","article-title":"Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker","volume":"334","author":"Abbadie","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.03.015_bib0080","first-page":"457","article-title":"Voltage-gated calcium channels as targets for the treatment of chronic pain","volume":"3","author":"McGivern","year":"2004","journal-title":"Curr Drug Tar"},{"key":"10.1016\/j.bcp.2014.03.015_bib0085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1602\/neurorx.2.4.662","article-title":"Targeting chronic and neuropathic pain: the N-type calcium channel comes of age","volume":"2","author":"Snutch","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bcp.2014.03.015_bib0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2005.04.035","article-title":"Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain","volume":"70","author":"Winquist","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0095","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.81.20.6388","article-title":"Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state","volume":"81","author":"Bean","year":"1984","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.03.015_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-6147(87)90011-3","article-title":"Common modes of drug action on Na channels: local anesthetics, antiarrhymics and anticonvulsants","volume":"8","author":"Catterall","year":"1987","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bcp.2011.10.019","article-title":"A-1048400 is a novel, orally active, state-dependent neuronal Ca2+ channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats","volume":"83","author":"Scott","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00011-011-0322-9","article-title":"Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels","volume":"60","author":"Vortherms","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2014.03.015_bib0115","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/adt.2006.4.689","article-title":"A nonadherent cell-based HTS assay for N-type calcium channel using calcium 3 dye","volume":"4","author":"Lubin","year":"2006","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/adt.2006.054","article-title":"Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches","volume":"5","author":"Xie","year":"2007","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0125","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1124\/mol.107.043612","article-title":"Activation of corticotropin releasing factor receptor 1 selectively inhibits Cav3.2 T-type calcium channels","volume":"73","author":"Tao","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/jpet.105.084103","article-title":"A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid","volume":"314","author":"El Kouhen","year":"2005","journal-title":"J Pharmacol Expt Ther"},{"key":"10.1016\/j.bcp.2014.03.015_bib0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0022-3565(24)37423-3","article-title":"ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization","volume":"285","author":"Bannon","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.03.015_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2009.04.009","article-title":"Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis","volume":"613","author":"Chandran","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bcp.2014.03.015_bib0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2004.03.010","article-title":"Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model","volume":"110","author":"Lynch","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuroscience.2006.08.005","article-title":"Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity","volume":"143","author":"Joshi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2014.03.015_bib0175","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1152\/jn.90768.2008","article-title":"Contributions of central and peripheral TRPV1 receptors to mechanically evoked and spontaneous firing of spinal neurons in inflamed rats","volume":"100","author":"McGaraughty","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0180","article-title":"Primary observation (Irwin) test in rodents for assessing toxicity of test agent and its effects on behavior and physiological function","author":"Roux","year":"2005","journal-title":"Curr Protoc Pharmacol"},{"issue":"6","key":"10.1016\/j.bcp.2014.03.015_bib0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/chan.4.6.14106","article-title":"Contributions of T-type calcium channel isoforms to neuronal firing","volume":"4","author":"Cain","year":"2010","journal-title":"Channels"},{"key":"10.1016\/j.bcp.2014.03.015_bib0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbb.2010.07.018","article-title":"a new T-type calcium channel antagonist has an antinociceptive effect on inflammatory and neuropathic pain models","volume":"97","author":"Lee","year":"2010","journal-title":"Pharmcol Biochem Behav"},{"key":"10.1016\/j.bcp.2014.03.015_bib0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2008.10.004","article-title":"Regualtion of neuronal T-type calcium channels","volume":"30","author":"Iftinca","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0200","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1745-7254.2006.00461.x","article-title":"Intrathecal administration of Cav3.2 and Cav 3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion","volume":"12","author":"Wen","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bcp.2014.03.015_bib0205","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1523\/JNEUROSCI.2919-09.2009","article-title":"T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids","volume":"42","author":"Barbara","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.03.015_bib0210","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1016\/j.bmc.2010.06.082","article-title":"Synthesis and T-type calcium channel activity of novel diphenylpiperazine compounds and evaluation of in vivo analgesic activity","volume":"18","author":"Kam","year":"2010","journal-title":"Biol Med Chem"},{"key":"10.1016\/j.bcp.2014.03.015_bib0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3959(03)00177-5","article-title":"Reversal of experimental neuropathic pain by T-type calcium channel blockers","volume":"105","author":"Dogrul","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0220","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jpain.2005.09.007","article-title":"Calcium channels as therapeutic targets in neuropathic pain","volume":"7","author":"Yaksh","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0225","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.pain.2010.12.035","article-title":"A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain","volume":"152","author":"Hildebrand","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0230","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/mol.111.073205","article-title":"TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent","volume":"80","author":"Choe","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2014.03.015_bib0235","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel and vincristine induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0240","article-title":"Mechanistic insights into the analgesic efficacy of A-1264087, a novel neuronal Ca2+ channel blocker that reduces nociception in rat preclinical pain models","author":"Zhu","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.bcp.2014.03.015_bib0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2013.08.004","article-title":"Voltage gated sodium and calcium channel blockers for the treatment of inflammatory pain","volume":"557","author":"Rahman","year":"2013","journal-title":"Neurosci Lett"}],"updated-by":[{"DOI":"10.1016\/j.bcp.2015.02.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:58:29Z","timestamp":1757768309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214002020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0006295214002020"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.03.015","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcp.2015.02.008","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}